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Nuclear Reprogramming
by Human Embryonic Stem Cells
Embryonic stem cells have two unique properties.
They are capable of indefinite self-renewal and, being
pluripotent, they can differentiate into all possible cell
types, including germ cells. A new study by Cowan
et al. (2005) published in Science shows that human
embryonic stem cells are able to reprogram the nuclei
of fully differentiated human somatic cells, apparently
conferring on them a pluripotent state.
The possibility of regenerating the entire repertoire of
diverse cell types from an adult somatic cell, such as a
skin cell, is an alluring thought. However, development
from a totipotent fertilized egg involves progressive
loss of pluripotency as cells commit to become defined
cell types, such as nerves or muscle. Essentially, there
is no way back for these differentiated cells without the
help of experimental manipulation. In contrast, pluripo-
tent embryonic stem cells (ESCs) derived from early
mouse or human embryos consisting of 60 to 100 cells
at the blastocyst stage can proliferate indefinitely in
culture and retain the capacity to differentiate into all
cell types present in adults (Smith, 2001). Is it possible
somehow to confer this unique property from ESCs di-
rectly to adult somatic cells? Building on the work of
Tada et al. (2001), Cowan and colleagues now report in
Science that the answer to this question is a qualified
yes. The process involved is called nuclear reprogram-
ming as it entails a journey back to the beginning of de-
velopment.
The process of development and cellular differentia-
tion is accompanied by heritable modifications to the
DNA sequence, principally methylation of CpG dinucle-
otides. The histone proteins that are bound to DNA are
also subject to modifications, including methylation
and acetylation. All of these modifications ensure that
appropriate genes are selected for expression or re-
pression as part of the generation of diverse cell types.
These are epigenetic modifications, as they do not alter
the genetic blueprint, which remains essentially un-
changed in all cells. They are robust and heritable mod-
ifications, and as such ensure that differentiated cells in
adults retain their appropriate properties and individualidentity throughout adulthood. These modifications have
to be erased and re-set during nuclear reprogramming.
The most dramatic demonstration of nuclear repro-
gramming is seen following the transfer of a somatic
cell nucleus from an adult to an enucleated oocyte (un-
fertilized egg) (Rideout et al., 2001), a technique that
has been used to generate a number of different cloned
mammals since the breakthrough with Dolly the sheep
(Wilmut et al., 1997). The efficiency of the process, how-
ever, remains disappointingly low, and the underlying
mechanisms involved are virtually unknown. Perhaps
oocytes are deficient in factors necessary to erase
some types of epigenetic modifications efficiently. Oo-
cytes are also very complex cells as they undergo a
stereotypic developmental program to which a donor
somatic cell nucleus must adapt rapidly. Furthermore,
mammalian oocytes are both relatively small and not
very numerous, which precludes some studies, such as
biochemical approaches to identify the key reprogram-
ming factors present in the oocyte. The use of ESCs by
comparison represents a relatively uncomplicated al-
ternative for studying nuclear reprogramming and for
identifying key nuclear reprogramming factors.
One approach to examine whether ESCs can re-
program somatic cell nuclei is to generate heterokary-
ons by fusing ESCs with somatic cells (Blau and Blakely,
1999). In one such study where mouse ESCs were fused
with T cells, analysis of such hybrid cells showed that
the somatic nucleus did indeed acquire characteristics
of the ESCs with which the somatic cells were fused
(Tada et al., 2001). In the new work, Cowan and col-
leagues investigated whether human ES cells (hESCs)
fused to human somatic fibroblasts can reprogram the
fibroblast nuclei and render these cells pluripotent
(Cowan et al., 2005). Their study reveals that the human
fibroblast nucleus is reprogrammed in these hybrid
cells. First, the original somatic fibroblast nucleus
showed expression of genes associated with pluripo-
tency, while the expression of fibroblast-specific genes
was repressed. Second, the ESC-fibroblast hybrid cell
exhibited properties akin to those of hESCs, including
the capacity for self-renewal over at least 50 passages
and the ability to differentiate into a variety of cell types.
Finally, OCT4, a key pluripotency-specific gene that is
repressed in mature fibroblasts with a methylated pro-
moter region, became unmethylated, a necessary step
for reinitiation of its expression. This is a heritable epi-
genetic modification, which suggests that the effects
may not be just transient but could endure subse-
quently. Overall, the experiments suggest that hESCs
probably contain key reprogramming factors that can
modify a somatic cell nucleus, returning it to a pluripo-
tent state.
This approach while encouraging requires careful
considerations. First, the efficiency of the fusion pro-
cess between hESCs and somatic cells is very low. This
necessitates the use of drugs to select for productive
hybrids from among the vast pool of unfused cells. The
selection process takes about 10 days, which is a dis-
advantage as it precludes systematic investigation of
the early events leading up to nuclear reprogramming.
On the other hand, the prolonged exposure of the so-
matic nucleus to “reprogramming” factors from the
ESC nucleus in hybrid cells may be an advantage. Sec-
Cell
654ond, we cannot say unequivocally that the somatic cell
nucleus is reprogrammed as it coexists with the original
chromosomes from the ESC in the hybrid cell. To be
sure, the ESC chromosomes need to be eliminated
from the hybrid cell to see if the somatic cell nucleus
continues to display its new identity. Of course, being
able to remove the ESC chromosomes while retaining
the reprogrammed somatic nucleus would make this
procedure extremely valuable even if we do not under-
stand the mechanism. However, this is not possible at
present. Nevertheless, the likelihood that hESCs have
the potential to reprogram somatic cell nuclei is a big
step forward because it means that there is a large vol-
ume of biological material available for biochemical
characterization of the reprogramming factors present
in these cells. There is also the potential to develop cell-
based assays to hunt for these key reprogramming
factors.
But we also need to know the nature of the repro-
gramming factors themselves. A key requirement dur-
ing reprogramming is the efficient erasure of existing
epigenetic modifications associated with DNA and his-
tones. Are oocytes and ESCs equivalent in this re-
spect? Some studies suggest that certain forms of his-
tone modifications may be erased more efficiently in
the pluripotent epiblast compared to oocytes (Bao et
al., 2005; Santos et al., 2003). If ESCs inherit this prop-
erty from epiblast cells from which they are derived,
then this could make ESCs in some respects more effi-
cient at reprogramming somatic cells. The recent iden-
tification of a histone demethylase called LSD1 (Lee et
al., 2005; Metzger et al., 2005) could be an important
step forward if this or similar molecules have a role in
nuclear reprogramming. Indeed, we need to under-
stand the mechanism of nuclear reprogramming in
much greater detail, and the Cowan et al. study is cer-
tainly a step in this direction.
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